Pfizer CEO Albert Bourla said its COVID-19 vaccine will be ready this year, PrimeTime reported.
The drugmaker is conducting clinical trials in the US and Europe for the BNT 1662 vaccine programme for the prevention of COVID-19 in collaboration with BioNTech.
Bourla said that if things go well and the FDA and the European Medicines Agency feel comfortable, the vaccine will be available by the end of October.
To read more NewsPoints articles, click here.
About FirstWord Pharma | Upgrade Your FirstWord Pharma | Contact FirstWord Pharma | FirstWord Reports
Advertise with FirstWord Pharma | Industry Partner Showcase
All Contents Copyright © 2021 Doctor's Guide Publishing Limited. All Rights Reserved.
Terms of Use | Privacy Policy